Please note our Product Finder does not contain our complete product portfolio. Should you wish for further information on a specific product, please contact us.
Contact customer care

La Madeleine, France, – July 8, 2024. Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, and Bonumose, a pioneer in enzymatic solutions for rare monosaccharide production, are pleased to announce the signing of a Cooperation Agreement that aims to advance the development of tagatose, a natural-origin sweetener with clinically proven health benefits.

This collaboration combines Roquette's extensive experience in starch and starch-based sweetener production with Bonumose's cutting-edge enzymatic technology. By leveraging the strengths of both companies, the agreement aims to enhance the scalability of tagatose, reaffirming Roquette’s commitment to innovative sugar management solutions.

“Roquette is proud to partner with Bonumose to advance tagatose growth,” expresses Anne Hirsch, Head of Sugar Management at Roquette. “We recognize the potential of Bonumose’s innovative enzyme technology, which produces high-purity tagatose. Our large-scale starch sweetener production expertise can significantly enhance processing efficiency post enzymatic conversion. This partnership aligns with our long-term vision of sustainable production and meeting the growing global demand for sweetening solutions.”

Ed Rogers, CEO of Bonumose, adds: “Tagatose closely matches the taste, flavor, and cookability of white sugar while offering health benefits such as reduced calories and an ultra-low glycemic index. We are excited to collaborate with Roquette, given their engineering prowess, and multiple market routes. We are happy to welcome Roquette into our expanding ecosystem of strategic partners supporting tagatose adoption.”

About Roquette
To learn more about Roquette, please visit this page.

About Bonumose
Bonumose is a later-stage startup food ingredient and enzyme innovation company based in Albemarle County, Virginia, United States. Bonumose is supported by strategic investors, “food for health”-focused institutional investors, and a network of global collaboration partners across the value chain, including long-standing partner, ASR Group. Bonumose developed and patented the Bonumose® method for continuous production of high-purity Tagatose, Allulose and other good-for-you ingredients from abundant, plant-based feedstocks. Beyond sugar alternatives, Bonumose also has solutions for dietary supplements, crop protection, animal nutrition, and other globally significant industries. Due to the public health significance of Bonumose’s innovations, the World Economic Forum named Bonumose as a “Technology Pioneer.” Bonumose operates with a philosophy of Business as a Moral Imperative and believes in the power of market incentives to solve intractable problems.

Bonumose’s Tagatose is certified/verified as Prebiotic, Ketogenic, Non-GMO, Plant-Based, Vegetarian, Kosher and Halal.

Media Contacts